<code id='9C65761342'></code><style id='9C65761342'></style>
    • <acronym id='9C65761342'></acronym>
      <center id='9C65761342'><center id='9C65761342'><tfoot id='9C65761342'></tfoot></center><abbr id='9C65761342'><dir id='9C65761342'><tfoot id='9C65761342'></tfoot><noframes id='9C65761342'>

    • <optgroup id='9C65761342'><strike id='9C65761342'><sup id='9C65761342'></sup></strike><code id='9C65761342'></code></optgroup>
        1. <b id='9C65761342'><label id='9C65761342'><select id='9C65761342'><dt id='9C65761342'><span id='9C65761342'></span></dt></select></label></b><u id='9C65761342'></u>
          <i id='9C65761342'><strike id='9C65761342'><tt id='9C65761342'><pre id='9C65761342'></pre></tt></strike></i>

          focus

          focus

          author:Wikipedia    Page View:52
          Attendees at the MedTech Conference in Anaheim, California. -- health tech coverage from STAT
          Attendees at the AdvaMed Conference in Anaheim, Calif., on Tuesday. Eric Thayer for STAT

          ANAHEIM, Calif. — Thousands of workers in the medical device industry gathered here this week for the MedTech Conference, creating an eerie dissonance with Disneyland tourists clad in Mickey Mouse ears and fanny packs.

          Device makers and analysts at the conference, hosted by device lobby AdvaMed, came together to discuss medical technology’s innovation problem, the industry’s deepening relationship with the Food and Drug Administration, and the growing opportunities in digital health.

          advertisement

          After a couple of years of tremendous gains generated by the pandemic’s demand for medical equipment, the medical device industry has hit a slump. In its annual medtech report, EY reported a 30% decline in all industry financing, which includes a drop in initial public offerings, special-purpose acquisition company deals, and venture capital funding.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          FDA approves Sage Therapeutics’ rapid
          FDA approves Sage Therapeutics’ rapid

          AndrewHarnik/APTheFoodandDrugAdministrationonFridayapprovedanew,rapid-actingmedicinemadebySageTherap

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          With fresh data, a dynamic duo powers Eli Lilly to new heights

          EliLillyCEODavidRicks(left)andChiefScientificOfficerDanielS.SkovronskyMollyFergusonforSTATThepartner